Market closedNon-fractional

Biomea Fusion/BMEA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Biomea Fusion

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Ticker

BMEA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Redwood City, United States

Employees

110

Biomea Fusion Metrics

BasicAdvanced
$156M
Market cap
-
P/E ratio
-$3.57
EPS
-0.54
Beta
-
Dividend rate
$156M
-0.54
5.843
5.738
5.857
8.197
-60.99%
-116.52%
1.15
1.15
-1.477
10.89%
55.37%

What the Analysts think about Biomea Fusion

Analyst Ratings

Majority rating from 8 analysts.
Buy

Biomea Fusion Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$39M
12.07%
Profit margin
0.00%
NaN%

Biomea Fusion Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 9.64%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.70
-$0.80
-$0.98
-$1.09
-
Expected
-$0.88
-$0.82
-$0.85
-$0.99
-$1.07
Surprise
-20.01%
-2.81%
15.09%
9.64%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Biomea Fusion stock?

Biomea Fusion (BMEA) has a market cap of $156M as of July 06, 2024.

What is the P/E ratio for Biomea Fusion stock?

The price to earnings (P/E) ratio for Biomea Fusion (BMEA) stock is 0 as of July 06, 2024.

Does Biomea Fusion stock pay dividends?

No, Biomea Fusion (BMEA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Biomea Fusion dividend payment date?

Biomea Fusion (BMEA) stock does not pay dividends to its shareholders.

What is the beta indicator for Biomea Fusion?

Biomea Fusion (BMEA) has a beta rating of -0.54. This means that it has an inverse relation to market volatility.

Buy or sell Biomea Fusion stock

Buy or sell Biomea Fusion stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing